Novartis adquire desenvolvedora de tratamento contra câncer de medula óssea por US$ 2,9 bilhões
February 06 2024 - 2:15PM
Newspaper
/jornal/2024/02/novartis-adquire-desenvolvedora-de-tratamento-contra-cancer-de-medula-ossea-por-us-2-9-bilhoes/
Novartis (BOV:N1VS34)
Historical Stock Chart
From Jun 2024 to Jul 2024
Novartis (BOV:N1VS34)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Novartis AG (Brazil Bovespa Exchange): 0 recent articles
More News Articles